Drug price regulator exempts Meril Life Sciences from price controls for a stent developed 3 years ago

This means that the firm has provided adequate justification to the government for launching its product at “any price" it wants. Meril Life’s first locally made biodegradable cardiac scaffold, a naturally dissolving stent, known as MeRes100 will be expected from price controls for the next five years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TnwN3V
via IFTTT